N-Nitroso Aripiprazole

N-Nitroso Aripiprazole is also known as Aripiprazole Nitroso Impurity a nitrosamine-related impurity derived from Aripiprazole, an atypical antipsychotic medication used in the treatment of schizophrenia, bipolar disorder, and major depressive disorder. N-Nitroso Aripiprazole is a nitrosamine impurity and pharmaceutical reference standard associated with Aripiprazole, widely used in impurity profiling, nitrosamine testing, analytical method development, and pharmaceutical quality control. With a molecular formula of C₂₃H₂₆Cl₂N₄O₃ and a molecular weight of 477.38 g/mol, it is utilized in LC-MS/MS, HPLC, and GC-MS analysis for the detection and quantification of trace nitrosamine impurities in APIs and finished formulations. This reference standard supports genotoxic impurity assessment, drug safety studies, stability testing, and regulatory compliance with ICH, FDA, and EMA guidelines. Manasa Life Sciences is a trusted manufacturer and supplier of N-Nitroso Aripiprazole, providing comprehensive CoA, SDS, and MSDS documentation to ensure quality, traceability, and regulatory compliance for pharmaceutical research and testing applications.